(Q46915446)

26 December 2017

meta-analysis

0 references

title

The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis (English)

1 reference

26 December 2017

0 references

1 reference

Kui Zhang

1

1 reference

26 December 2017

Xiao-qin Wang

series ordinal

2

1 reference

26 December 2017

Bin Zhou

series ordinal

3

1 reference

26 December 2017

Lin Zhang

series ordinal

4

1 reference

26 December 2017

publication date

1 September 2013

1 reference

26 December 2017

published in

Familial Cancer

1 reference

26 December 2017

volume

12

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

449-458

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s10689-013-9607-1

exact match

0 references

cites work

DNA methylation in glioblastoma: impact on gene expression and clinical outcome

1 reference

12 December 2020

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

12 December 2020

Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas

1 reference

12 December 2020

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

12 December 2020

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

1 reference

12 December 2020

Quantifying heterogeneity in a meta-analysis

1 reference

12 December 2020

Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin.

1 reference

12 December 2020

Molecular genetic markers as predictors of response to chemotherapy in gliomas

1 reference

12 December 2020

Standard therapy for glioblastoma--a review of where we are.

1 reference

12 December 2020

Repair of O(6)-alkylguanine by alkyltransferases

1 reference

12 December 2020

Operating characteristics of a rank correlation test for publication bias

1 reference

12 December 2020

O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radio

1 reference

12 December 2020

Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients.

1 reference

12 December 2020

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

12 December 2020

O⁶-methylguanine-DNA-methyltransferase promoter methylation assessment by microdissection-assisted methylation-specific PCR and high resolution melting analysis in patients with glioblastomas.

1 reference

12 December 2020

Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.

1 reference

12 December 2020

p15 promoter methylation - a novel prognostic marker in glioblastoma patients.

1 reference

12 December 2020

An integrated genomic analysis of human glioblastoma multiforme

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Malignant gliomas in adults

1 reference

12 December 2020

Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study.

1 reference

12 December 2020

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

1 reference

12 December 2020

Long-term survivors of glioblastoma: clinical features and molecular analysis

1 reference

12 December 2020

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference

1 reference

12 December 2020

The 2007 WHO classification of tumours of the central nervous system

1 reference

12 December 2020

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients.

1 reference

12 December 2020

Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed gl

1 reference

12 December 2020

Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide

1 reference

12 December 2020

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

12 December 2020

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms

1 reference

12 December 2020

DNA damage tolerance, mismatch repair and genome instability

1 reference

12 December 2020

MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.

1 reference

12 December 2020

Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide

1 reference

12 December 2020

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

1 reference

12 December 2020

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications

1 reference

12 December 2020

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.

1 reference

12 December 2020

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.

1 reference

12 December 2020

MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

1 reference

12 December 2020

Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma

1 reference

12 December 2020

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back?

1 reference

12 December 2020

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas

1 reference

12 December 2020

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

1 reference

12 December 2020

Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain.

1 reference

12 December 2020

Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.

1 reference

12 December 2020

INI1 immunohistochemical expression in glioblastoma: correlation with MGMT gene promoter methylation status and patient survival.

1 reference

12 December 2020

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma

1 reference

12 December 2020

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.

1 reference

12 December 2020

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary.

1 reference

12 December 2020

Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations

1 reference

12 December 2020

10.1007/S10689-013-9607-1

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017